VA-HILTON
12.6.2020 06:03:12 CEST | Business Wire | Press release
Next week, Hilton will begin a worldwide roll-out of a new program to deliver an industry-defining standard of cleanliness and disinfection to Hilton properties. Hilton CleanStay, created in collaboration with Lysol and Dettol maker RB and Mayo Clinic, includes new procedures to help Hilton guests enjoy an even cleaner and safer stay starting this summer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200611005920/en/
Hilton and RB have expanded this partnership to support the global portfolio of hotels and the trusted RB family of products will be used in multiple markets around the world.
“For more than a century, our top priority has been the safety and security of our guests and Team Members. As the hospitality industry evolves to address travelers’ changing expectations – especially in the wake of the coronavirus pandemic – Hilton CleanStay is the latest evolution of our commitment to providing the peace of mind and confidence our guests need to travel freely, while protecting our Team Members,” said Chris Nassetta, President and CEO of Hilton.
“Though our hospitality may look different in the short term, around the world we are eager to welcome our guests once more and create the unforgettable experiences they have come to expect from Hilton.”
Hilton guests can expect to begin seeing changes in some hotels around the world starting next week, with Hilton CleanStay implemented across Hilton’s 18 brands by mid-July.
Hilton CleanStay from Check-in to Check-out
- Online: Even before they travel, guests will find a new landing page at Hilton.com/cleanstay which will detail what they can expect during their stay. In addition, property websites will be updated to indicate that the new cleaning protocols and procedures have been implemented.
- The Lobby: Guests who desire a contactless arrival experience can check-in, choose their room, unlock their door with a Digital Key and check-out using their mobile devices through the free Hilton Honors mobile app. This option is available at more than 4,700 participating Hilton properties worldwide for guests who book direct via the Honors app or at Hilton.com. For guests who prefer a traditional check-in, physical distancing measures will be in place directing guests on how to move through the in-person check-in and check-out process in a safe way.
- The Guest Room: The first point of contact with the guest room will be with the Hilton CleanStay room seal, placed on the door upon being thoroughly cleaned. The room will have extra disinfection of the most frequently touched guests room areas – light switches, door handles, TV remotes, thermostats and more. It will be de-cluttered, with items like pens and paper removed. Disinfecting wipes will be provided in every room for guest use.
- Housekeeping Service: Guest rooms will be thoroughly cleaned and disinfected between guests. Housekeeping service during a guest stay will be based upon guest preference, recognizing that some guests may not want staff entering their room. Additional amenities such as linens and toiletries will be available upon request, delivered in protective packaging and placed at the guest room door.
- The Public Spaces: There will be increased frequency of cleaning public areas. For instance, fitness centers may be closed for cleaning multiple times daily. Equipment will be properly adjusted and placed to enable physical distancing, and the number of guests in the center may be limited. Pool and pool areas will be cleaned frequently throughout the day, and physical distancing measures will be in place. Stations with hand sanitizer and disinfecting wipes will be available throughout the property at primary entrances and in key high traffic areas.
- Food and Beverage: In hotel restaurants, tables and chairs will be spaced to ensure proper physical distancing. Biodegradable, disposable dishes/utensils will be available upon request. During breakfast, restaurants will offer a range of options including grab & go, pre-plated covered items, à la carte and assisted service. When ordering room service where it is provided, guests will experience contactless delivery, with orders and single-use serviceware placed outside their guestroom door.
- Meetings & Events: The upcoming Hilton EventReady with CleanStay program will set a new standard for meetings and events at Hilton. This program will deliver cleanliness, flexibility, safe and socially responsible solutions, along with creative food and beverage, the latest technology and sustainable practices. With a dedicated focus on health and wellness, the event experience from planning to execution is backed by Hilton’s world-class hospitality with responsive service from dedicated Team Members.
Since the initial announcement of the partnership, RB has worked with Hilton to deploy plans for global execution of Hilton CleanStay. In the United States and Canada, Hilton CleanStay will be implemented using Lysol products and the program will be referred to as Hilton CleanStay with Lysol protection. While Lysol and Dettol will be the most prominently used products in countries where Hilton has properties, other RB brands will also be used, including Sagrotan in Germany and Napisan in Italy.
The scientific expertise of RB is second-to-none and the use of its products assures consumers around the world of a safer stay. According to recent findings of a study published by the American Journal of Infection Control , the active ingredients in Dettol and Lysol are effective in breaking the chain of infection of COVID-19.
“Protecting people from illness is core to RB and our global germ prevention portfolio,” said Rahul Kadyan, EVP, North America, Hygiene/Home, RB. “Our brands are built on trust, scientific efficacy and our desire to educate consumers around the world to help break the chain of infection. This is an ideal partnership for RB to help drive the highest standards in hygiene and give consumers confidence to enjoy the Hilton experience.”
Throughout the development of Hilton CleanStay, Mayo Clinic has offered their medical expertise to advise Hilton on training methods, cleaning protocols and quality assurance. Additionally, Mayo Clinic has advised on new technologies and methods from the healthcare industry that can benefit the cleanliness and disinfection programs at Hilton hotels.
“Personal safety is extremely critical as we re-open business and recreational activities around the globe,” said Stacey Rizza, M.D., a Mayo Clinic infectious disease specialist. “We are proud to bring Mayo Clinic’s expertise and knowledge to the COVID-19 response on a national and global scale. Mayo is honored to work with Hilton staff and to advise them on the program protocol and training.”
Elements of Hilton CleanStay will greet guests from the moment they enter the hotel and will be present throughout every aspect of the experience, ensuring the well-being of guests and Team Members without compromising the hospitality Hilton is known for.
As a part of Hilton’s new standard of hotel cleanliness and sanitization, training was designed to ensure all Team Members are aware of the steps they can take to keep themselves and others healthy while at work. During a stay, guests may encounter Team Members using creative ways to welcome them and demonstrate their hospitality while wearing protective equipment and staying respectful of physical distance.
About Hilton
Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 18 world-class brands comprising more than 6,100 properties with more than 977,000 rooms, in 118 countries and territories. Dedicated to fulfilling its mission to be the world’s most hospitable company, Hilton welcomed more than 3 billion guests in its 100-year history, earned a top spot on the 2019 World’s Best Workplaces list, and was named the 2019 Global Industry Leader on the Dow Jones Sustainability Indices. Through the award-winning guest loyalty program Hilton Honors, more than 106 million members who book directly with Hilton can earn Points for hotel stays and experiences money can’t buy, plus enjoy instant benefits, including digital check-in with room selection, Digital Key, and Connected Room. Visit newsroom.hilton.com for more information, and connect with Hilton on Facebook , Twitter , LinkedIn , Instagram and YouTube .
About RB
RB* is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone. RB is proud to have a stable of trusted household brands found in households in more than 190 countries. These include Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite, Air Wick and more. 20 million RB products a day are bought by consumers globally.
RB’s passion to put consumers and people first, to seek out new opportunities, to strive for excellence in all that we do, and to build shared success with all our partners, while doing the right thing, always is what guides the work of our 40,000+ diverse and talented colleagues worldwide. For more information visit www.rb.com .
*RB is the trading name of the Reckitt Benckiser group of companies
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news and An Inside Look at Mayo Clinic for more information about Mayo.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200611005920/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
